LPA2 receptor-containing complexes in regulating secretory diarrhea
含 LPA2 受体的复合物调节分泌性腹泻
基本信息
- 批准号:8698411
- 负责人:
- 金额:$ 30.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-15 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAgonistAnimal ModelApicalCell LineCell membraneCellsCessation of lifeChildhoodChloride ChannelsChloride IonChloridesCholeraCholera ToxinComplexCoupledCyclic AMPCystic Fibrosis Transmembrane Conductance RegulatorDiarrheaDiseaseEdg4 ProteinElderlyElectrolytesEpithelial CellsEventExocrine GlandsFluids and SecretionsGenerationsHospitalizationHumanIncidenceInflammatory Bowel DiseasesIntestinesKnockout MiceLysophosphatidic Acid ReceptorsMacromolecular ComplexesMediatingModelingMolecularMultiprotein ComplexesMusPhysiciansPhysiologicalPlayPopulationProcessRegulationResearchRoleSignal PathwaySignal TransductionSodium ChlorideSurfaceTestingTherapeutic InterventionUnited StatesVisitWaterattenuationgastrointestinal epitheliumin vivoinnovationmouse modelprotein protein interactionreceptor expressionreceptor-mediated signalingresponsesmall hairpin RNAsodium-hydrogen exchanger regulatory factortechnology/technique development
项目摘要
DESCRIPTION (provided by applicant): The unifying hypothesis of this proposal is that macromolecular complex of type 2 lysophosphatidic acid receptor (LPA2 receptor) and Na+/H+ exchange regulatory factor-2 (NHERF2) plays important roles in the pathogenic process of secretory diarrhea. We aim to study the formation and regulation of the macromolecular complex at the molecular level under physiological and pathophysiological conditions that play a critical role in cholera induced diarrhea. Moreover, the research will study the mechanism through which LPA2 receptor- mediated signaling events regulate CFTR-dependent electrolyte secretion in cells and fluid secretion in an animal model of diarrhea. Three aims will be studied: Aim 1: To test the hypothesis that LPA2 receptor is primarily expressed on the luminal surface of the gut and is down regulated in certain forms of diarrheal diseases, and to test the hypothesis that activation of LPA2 receptor inhibits compartmentalized cAMP generation at the plasma membrane. Aim 2: To test the hypothesis that LPA can regulate the formation of the LPA2-containing macromolecular complex by further clustering it to microdomain on the plasma membrane and that the process is mediated by NHERF2-dependent protein-protein interactions Aim 3: To test the hypothesis that disruption of the macromolecular complex by silencing NHERF2 alters compartmentalized cAMP levels at the plasma membrane and that in vivo NHERF2 knockout mice generate altered cAMP in response to CTX. The proposal is of great importance and significance for understanding the pathogenic process of the deadly secretory diarrheal diseases at the molecular level, and for possible therapeutic intervention of the disease. The proposed study is highly innovative in both conceptual advance and in technology/technique development.
描述(由申请人提供):该提案的统一假设是2型溶血磷脂受体(LPA2受体)和Na+/H+交换调控因子2(NHERF2)的大分子复合物在秘密腹泻的致病过程中起着重要作用。我们旨在研究生理和病理生理条件下分子水平上大分子复合物的形成和调节,在霍乱诱导的腹泻中起着关键作用。此外,该研究将研究LPA2受体介导的信号事件通过细胞中CFTR依赖的电解质分泌的机制和腹泻动物模型中的液体分泌。将研究三个目的:目标1:测试LPA2受体主要在肠道表面表达的假设,并以某些形式的腹泻疾病调节,并测试以下假设,即LPA2受体的激活在Plasmambrane plasmambrane cancmentalizatizan camp Membrane的cAMP产生。目的2:测试LPA可以通过将其进一步聚集到质膜上的微分域来调节含LPA2的大分子复合物的形成的假设,并且该过程是由NHERF2依赖性蛋白质 - 蛋白质相互作用介导的,目的是在测试隔离阶级的隔离层的隔离层构造nherf2依赖性的蛋白质相互作用。质膜和体内NHERF2敲除小鼠对CTX的响应会改变cAMP。该提案对于理解分子水平上致命分泌性腹泻疾病的致病过程以及可能对疾病的治疗干预措施非常重要和重要性。拟议的研究在概念进步和技术/技术开发中都具有很高的创新性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anjaparavanda P Naren其他文献
Anjaparavanda P Naren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anjaparavanda P Naren', 18)}}的其他基金
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10406127 - 财政年份:2020
- 资助金额:
$ 30.54万 - 项目类别:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10454293 - 财政年份:2020
- 资助金额:
$ 30.54万 - 项目类别:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10656430 - 财政年份:2020
- 资助金额:
$ 30.54万 - 项目类别:
Personalized Cystic Fibrosis Therapy and Research Center
个性化囊性纤维化治疗和研究中心
- 批准号:
10672704 - 财政年份:2018
- 资助金额:
$ 30.54万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:82101697
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 30.54万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 30.54万 - 项目类别:
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:
10722943 - 财政年份:2023
- 资助金额:
$ 30.54万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 30.54万 - 项目类别:
Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesis
酒精诱导的 PPAR-α 表观遗传重编程影响异孕酮生物合成
- 批准号:
10658534 - 财政年份:2023
- 资助金额:
$ 30.54万 - 项目类别: